Silverarc Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.02M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $10.2M | Buy |
|
|||||
|
2023
Q1 | $2.26M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.3M | Sell |
|
|||||
|
2021
Q3 | $2.22M | Sell |
|
|||||
|
2021
Q2 | $2.42K | Buy |
|
|||||
|
2021
Q1 | $2.33M | Buy |
|
|||||
|
2020
Q4 | $2.44M | Buy |
|